Shopping Cart
- Remove All
- Your shopping cart is currently empty
17-phenyl trinor Prostaglandin F2α (17-phenyl trinor PGF2α) is a metabolically stable analog of PGF2α and is a potent agonist for the FP receptor, binding with a relative potency of 756% compared to that of PGF2α. The ethyl amide of 17-phenyl trinor PGF2α bimatoprost has been approved for use as an ocular hypotensive drug. 17-phenyl trinor PGF2α methyl amide is an analog of bimatoprost. Its biological and toxicological properties have not been evaluated.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | 35 days | |
5 mg | Inquiry | 35 days | |
10 mg | Inquiry | 35 days | |
50 mg | Inquiry | 35 days |
Description | 17-phenyl trinor Prostaglandin F2α (17-phenyl trinor PGF2α) is a metabolically stable analog of PGF2α and is a potent agonist for the FP receptor, binding with a relative potency of 756% compared to that of PGF2α. The ethyl amide of 17-phenyl trinor PGF2α bimatoprost has been approved for use as an ocular hypotensive drug. 17-phenyl trinor PGF2α methyl amide is an analog of bimatoprost. Its biological and toxicological properties have not been evaluated. |
Alias | 17-phenyl trinor Prostaglandin F2α methyl amide |
Molecular Weight | 401.547 |
Formula | C24H35NO4 |
Cas No. | 155206-01-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMF: 25 mg/mL (62.26 mM), Sonication is recommended. PBS (pH 7.2): 300 μg/mL, Sonication is recommended. Ethanol: 50 mg/mL (124.52 mM), Sonication is recommended. Acetonitrile: 3 mg/mL (7.47 mM), Sonication is recommended. DMSO: 25 mg/mL (62.26 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Acetonitrile/DMF/DMSO/Ethanol
DMF/DMSO/Ethanol
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.